In this episode of Talking HealthTech, host Nathan Moore speaks with Stefan Mazy, the CEO of DermR Health Solutions. 

They discuss DermR Health's innovative approach to diagnosing skin cancer through their DermR Patch technology. 

Stefan shares his personal motivation behind the technology and the journey of developing a solution to improve diagnostic accuracy while reducing the burden on healthcare systems worldwide.

Key Takeaways:

• DermR Patch technology offers a novel approach to skin cancer diagnosis using a microsampling tool that can potentially reduce unnecessary biopsies, which is projected to save significant healthcare costs and improve patient outcomes.

• The current global challenge with skin cancer diagnostics is the over-reliance on biopsies, with a significant percentage being unnecessary.

• The technology also addresses incorrect data classifications in skin cancer statistics, aiming to provide more accurate data for informed health decisions.

• The potential for nurses and other healthcare professionals to administer the DermR Patch, demonstrating the potential for optimising healthcare resources.

• The anticipated decline in GPs and rise in skin cancer cases by 2030 highlights the need for innovative diagnostic solutions such as DermR Patch.

Check out the episode and full show notes on the Talking HealthTech website.

Loving the show? Leave us a review, and share it with someone who might get some value from it.

Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, meet-ups, special offers and more exclusive content. For more information visit talkinghealthtech.com/thtplus